James River Group Holdings, Inc. (JRVR) operates as a specialty property-casualty insurer through its Excess and Surplus Lines and Specialty Admitted Insurance segments. The third quarter 2026 report stands out because it tests whether the multi-year turnaround—focused on cost discipline, reserve remediation, and a shift toward more profitable underwriting—can hold up against legacy liabilities. The headline net loss stems from a non-cash goodwill impairment linked to the original 2007 acquisition, not from any operating deterioration. In my view, the real signals for investors sit below that charge: reserve development, submission growth, expense trends, and investment income all give a clearer picture of the franchise's durability.
For the third quarter of 2026, JRVR posted a net loss available to common shareholders of $189.4 million, or $4.08 per diluted share, compared with a net loss of $0.9 million, or $0.02 per share, in the same period a year earlier. A $181.8 million non-cash goodwill impairment, originating from the 2007 investor acquisition, dominated the result. On an adjusted basis, the company recorded a net operating loss of $4.4 million, or $0.10 per share, versus adjusted net operating income of $17.4 million, or $0.32 per share, in the prior-year quarter.
Gross written premium declined 22% to $186.1 million, in line with the intentional contraction of less profitable business. The annual reserve review generated $19.2 million of adverse development on about $1.0 billion of E&S net reserves, focused on a Product Liability portfolio now fully in runoff. On a positive note, G&A expenses dropped 9% year over year, and net investment income rose to $22.2 million, up more than 9% sequentially and 1% from a year earlier. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Investor reaction will likely center on separating the non-cash impairment from the underlying operating trends. Since the goodwill write-down leaves adjusted results, statutory capital, and debt covenants untouched, attention should turn to the $19.2 million adverse reserve development and the ongoing drop in gross written premium. The 8% increase in E&S new and renewal submissions and the 9% cut in G&A expenses offer some balance, indicating that repositioning toward profitable underwriting continues even as premium volume shrinks. Overall, the picture looks mixed: stronger near-term expense trends and submission momentum, tempered by reserve leakage in a legacy runoff book.
Looking ahead, the key question is whether the adverse reserve development in the runoff Product Liability portfolio stays contained or points to wider pressure across the E&S book. Management flagged a specific portfolio as the source, which could limit spillover risk, but later quarters will show if more strengthening is needed. Premium trends remain central. Gross written premium fell 22% amid deliberate de-risking, yet new and renewal submissions rose 8%, hinting at demand for the repositioned offerings. How quickly that submission growth turns into profitable written premium will signal the turnaround's path. Expense discipline and investment income provide further support. The 9% G&A decline and the sequential increase in net investment income to $22.2 million warrant tracking for sustainability, especially as the company invests in AI-enabled underwriting tools.
From what I see, incorporating AI-driven platforms into routine research helps surface comparable names and track shifting conditions more efficiently. One tool I rely on regularly is Tickeron’s AI Screener, which lets me filter stocks and ETFs by technical patterns, fundamentals, and performance metrics to gain additional context on names like JRVR without manual effort.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
JRVR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 09, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In 43 of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 88%.
The 10-day RSI Indicator for JRVR moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 13 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 54 cases where JRVR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JRVR as a result. In 78 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
JRVR moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JRVR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
JRVR broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 10-day moving average for JRVR crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where JRVR advanced for three days, in 180 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 81 of 128 cases where JRVR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JRVR's P/B Ratio (0.344) is slightly lower than the industry average of (0.987). P/E Ratio (7.939) is within average values for comparable stocks, (11.360). Projected Growth (PEG Ratio) (0.600) is also within normal values, averaging (0.944). Dividend Yield (0.010) settles around the average of (0.486) among similar stocks. JRVR's P/S Ratio (0.354) is slightly lower than the industry average of (2.529).
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. JRVR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JRVR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a insurance company
Industry SpecialtyInsurance